bariatric surgery vs semaglutide vs. GLP-1 Medications: What the Latest Research Shows Weight regain after meds, endoscopy,

FDA-approved tirzepatide (Zepbound) prescribed and managed under direct physician supervision as part of a structured GLP-1 therapy protocol

A Joint Advisory on nutritional support for GLP-1 therapy for obesity was issued by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society in May of 2025

Some telehealth providers offer compounded versions (e.g., semaglutide), which may be cheaper but lack FDA approval

Huang et al., 1993

The theory is that peak medication effects, including the most pronounced gastric slowing, occur 24-72 hours post-injection